FT Health Interviews Founder, Managing Director Of Medicines Development For Global Health

FT Health: Sackler saga; health inequality: Ebola strikes again
The latest issue of the Financial Times’ weekly global health newsletter features an interview with Mark Sullivan, founder and managing director of Medicines Development for Global Health, who discusses the organization’s efforts to address scabies, including research on the anti-helminth drug Moxidectin. The newsletter also provides a roundup of global health-related news stories (Jack, 3/29).